𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of low-dose total body irradiation and subcutaneous Interleukin-2 in metastatic melanoma

✍ Scribed by Akmal Safwat; Henrik Schmidt; Lars Bastholt; Kirsten Fode; Susanne Larsen; Ninna Aggerholm; Hans von der Maase


Book ID
118496553
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
83 KB
Volume
77
Category
Article
ISSN
0167-8140

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase I trial of subcutaneous recombinan
✍ Omar Eton; Michael G. Rosenblum; Sewa S. Legha; Wehei Zhang; Mary Jo East; Agop πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 3 views

## Abstract ## BACKGROUND Interleukin‐2 (IL‐2) has activity in metastatic melanoma when given in high doses by the intravenous (IV) route, but its side effects and effectiveness when given in intermediate to high doses by the subcutaneous (SC) route have not been studied adequately. This study sou